Ingesting Eye Drops, Nasal Sprays Can Make Children Sick, FDA Warns

Common redness reducing eye drops and decongestant nasal sprays may pose a much more serious health threat to small children than previously thought, according to federal health officials. 

The FDA released a drug safety communication yesterday, warning parents about risks associated with accidental ingestion of many common over-the-counter eye drops and nasal sprays, which can make children very ill and possibly lead to more severe side effects, such as coma.

According to reports received by the agency, adverse reactions have been seen among young children under the age of 5 years old, often leading to coma, decreased heart rate, decreased breathing and sleepiness.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The products listed in the warning all contain the active ingredient tetrahydrozoline, oxymetazoline, or naphazoline. Many of these products are sold as brand name products, generic products and under store brand labels. These products are typically sold in 5 mL and 30 mL bottle packages and are not sold with child-resistant packaging, making it easy for children to reach the product.

Officials warn that only 1 to 2 mL are required to cause such serious side effects in young children, which is approximately half a teaspoon of liquid or less. Researchers found a small dose of 1.5 mL to 3 mL of tetrahydrozoline 0.05% solution produced central nervous system and respiratory depression and bradycardia in a 25 day old infant and a 2 year old child. Additionally, 2 to 5 mL of the solution is enough to induce coma in a small child.

The FDA received 96 complaints of accidental eye drop or nasal spray swallowing in young children between 1985 and October of 2012 through its Adverse Event Reporting system. All the cases involved children under the age of 5 years.

In many cases the children were found chewing or sucking on the bottles or the bottles were found empty near them. In 53 cases, hospitalization occurred due to severe symptoms such as nausea, vomiting, lethargy, tachycardia, decreased respiration, bradycardia, hypotension, hypertension, sedation, somnolence, mydriasis stupor, hypothermia, drooling and coma.

The Consumer Product Safety Commission (CPSC) published a proposal requiring child-resistant packaging for redness relief eye drops and nasal decongestant spray products along with any products containing xylometazoline.

Products involved in the FDA warning containing tetrahydrozoline, naphazoline or oxymetazoline are Visine, Walgreens, Tyzine, GNP, Opti-Clear, Tetrahydrozoline, Today’s Health, Leader, Ak-Con, Napha Forte, Naphazoline, All Clear, Opcon-A, Naphcon A, 12 Hour, Afrin, Dristan, Equaline, Equate, Good Sense, Mucinex, Neo-Synephrine, Publix, Select Brand, Sinex, Sudafed, and Tope Care brand and products.

The FDA warns parents to store these over-the-counter drugs out of the reach of children. If a child ingests any of these products call the poison help line at 800-222-1222 and seek emergency medical attention.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.